Cargando…

Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis

INTRODUCTION: Psoriasis with and without arthritis have common immunological mechanisms which among others involve the interactions between cytokines produced by T cells, including Th1, Th17 and Th22. Although quite a lot is known about psoriasis pathogenesis, the cause of chronic immune activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartosińska, Joanna, Zakrzewska, Ewelina, Purkot, Joanna, Michalak-Stoma, Anna, Kowal, Małgorzata, Krasowska, Dorota, Chodorowska, Grażyna, Giannopoulos, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130132/ https://www.ncbi.nlm.nih.gov/pubmed/30206445 http://dx.doi.org/10.5114/ada.2018.75609

Ejemplares similares

Suppressed Programmed Death 1 Expression on CD4(+) and CD8(+) T Cells in Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2017)

Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients
por: Bartosińska, Joanna, et al.
Publicado: (2018)

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2021)

IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
por: Michalak-Stoma, Anna, et al.
Publicado: (2020)

The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023)

The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland
por: Bartosińska, Joanna, et al.
Publicado: (2015)

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022)

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
por: Bartosińska, Joanna, et al.
Publicado: (2021)

Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2013)

The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023)

Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities
por: Chyl-Surdacka, Katarzyna M., et al.
Publicado: (2019)

Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2021)

Videocapillaroscopic Alterations in Alopecia Areata
por: Gerkowicz, Agnieszka, et al.
Publicado: (2013)

The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development
por: Bartosińska, Joanna, et al.
Publicado: (2021)

PD1/PD-L1 pathway in psoriasis and psoriatic arthritis: a review
por: Adamczyk, Michał, et al.
Publicado: (2022)

Accumulation of CD5(+)CD19(+) B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils
por: Wlasiuk, Paulina, et al.
Publicado: (2015)

Selected miRNA and Psoriasis—Cardiovascular Disease (CVD)—Overweight/Obesity Network—A Pilot Study
por: Michalak-Stoma, Anna, et al.
Publicado: (2023)

The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment
por: Karpińska-Mirecka, Anna, et al.
Publicado: (2021)

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers
por: Wolska-Gawron, Katarzyna, et al.
Publicado: (2020)

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
por: Escors, David, et al.
Publicado: (2022)

Plasma Interleukin-18 and Dendritic Cells in Males with Psoriasis Vulgaris
por: Pietrzak, Aldona, et al.
Publicado: (2007)

Lipid Disturbances in Psoriasis: An Update
por: Pietrzak, Aldona, et al.
Publicado: (2010)

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
por: Grywalska, Ewelina, et al.
Publicado: (2017)

Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy
por: Zuazo, Miren, et al.
Publicado: (2020)

Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
por: Zuazo, Miren, et al.
Publicado: (2020)

Usefulness of Dermoscopy to Provide Accurate Assessment of Skin Cancers
por: Michalak-Stoma, Anna, et al.
Publicado: (2021)

Programmed Cell Death-1 and Its Ligands as Targets for Therapy of Multiple Myeloma Patients
por: Karczmarczyk, Agnieszka, et al.
Publicado: (2022)

Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis
por: Wawrzycki, Bartłomiej, et al.
Publicado: (2018)

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
por: Duchemann, Boris, et al.
Publicado: (2022)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study
por: Szczepanik-Kułak, Paulina, et al.
Publicado: (2022)

MicroRNA in localized scleroderma: a review of literature
por: Wolska-Gawron, Katarzyna, et al.
Publicado: (2019)

The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis
por: Karpińska-Mirecka, Anna, et al.
Publicado: (2020)

Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
por: Zuazo, Miren, et al.
Publicado: (2019)

Circulating Exhausted PD-1(+)CD39(+) Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade
por: Martinez-Gomez, Carlos, et al.
Publicado: (2022)

Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings
por: Latalska, Małgorzata, et al.
Publicado: (2020)

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells
por: Balança, Camille-Charlotte, et al.
Publicado: (2021)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

The Role of Vitamin D in Non-Scarring Alopecia
por: Gerkowicz, Agnieszka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tkhfj2k9fe3kqhadf2360jg9s2